Results 191 to 200 of about 86,203 (285)

National Bleeding Disorder Foundation Clinical Practice Recommendations for Laboratory Screening of Iron Deficiency With and Without Anemia in the Inherited Bleeding Disorders Population

Haemophilia, Volume 32, Issue 3, Page 646-657, May/June 2026.
ABSTRACT Introduction The National Bleeding Disorder Foundation (NBDF) Medical and Scientific Advisory Council (MASAC) was formed in 1954 and issues recommendations and advisories pertinent to the bleeding disorders community. MASAC is comprised of > 25 rotating members from different medical disciplines and lived experience experts.
Glaivy Batsuli, Magdalena D. Lewandowska, Ming Y. Lim, Kelly Tickle, Maureen K. Baldwin, Rose Bender, Jennifer Davila, Brendan Hayes, Amanda Jacobson‐Kelly, Peter Kouides, Michele P. Lambert, Shilpa Nataraj, Michelle Sholzberg, Roona Sinha, Hanny Al‐Samkari, Amy L. Dunn   +15 more
wiley   +1 more source

Association between gastric polyps and decreased bone mineral density in patients with chronic gastritis. [PDF]

Sci Rep
Liu G, Zhang J.
europepmc   +1 more source

Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels

Haemophilia, Volume 32, Issue 3, Page 731-738, May/June 2026.
ABSTRACT Introduction Valoctocogene roxaparvovec, an adeno‐associated virus (AAV)‐based gene therapy, enables endogenous factor VIII (FVIII) expression in patients with severe hemophilia A without the need for regular FVIII infusions. Long‐term follow‐up assesses durability, safety, and immune‐related challenges following gene therapy.
Kerstin Herbst, Behnaz Pezeshkpoor, Claudia Klein, Thilo Albert, Philipp Lutz, Christian Strassburg, Ulrich Spengler, Georg Goldmann, Johannes Oldenburg   +8 more
wiley   +1 more source

Association of Helicobacter pylori with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis. [PDF]

Medicina (Kaunas)
Ergün S, Kutluk F, Turgut BC, Dumur S, Sayılı U, Ergun DD, Uzun H.   +6 more
europepmc   +1 more source

High Eradication Rate of a Potassium‐Competitive Acid Blocker‐Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real‐World Study

Helicobacter, Volume 31, Issue 3, May/June 2026.
ABSTRACT Background Management of refractory Helicobacter pylori (H. pylori) infection remains challenging due to increasing antibiotic resistance and limited effective rescue options. Minocycline and furazolidone retain low resistance rates, while potassium‐competitive acid blockers (P‐CABs) provide potent and sustained acid suppression.
Ji‐Yan Li, Ying‐Ying Han, Dong‐Yan Li, Jing‐Mei Liu, Zhen‐Zhen Zhou, Ya‐Ni Zhou, Lin Tuo, Xiao‐Jiao Yao, Mei Liu, Ge Wang, Pei‐Yuan Li   +10 more
wiley   +1 more source

Comparative Efficacy and Safety of Stillen^® and Rebamipide in Patients with Acute or Chronic Gastritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. [PDF]

J Clin Med
Lee H, Lim NR, Kim S, Cho H, Chung WC.
europepmc   +1 more source

Incorporating Helicobacter pylori Infection: A Novel Model for Predicting Advanced Colorectal Neoplasia

Helicobacter, Volume 31, Issue 3, May/June 2026.
ABSTRACT Background and Aims Early detection of advanced colorectal neoplasia (ACN) is critical for reducing colorectal cancer (CRC) incidence and mortality. Existing prediction models exhibit limited discriminative power. This study aimed to develop and internally validate a novel risk prediction model for ACN, with particular emphasis on ...
Xujin Chen, Dehua Tang, Ningjing Gao, Muhan Ni, Peng Yan, Zhanwen Ji, Xiang Xin, Cheng Yang, Lei Wang, Qiang Zhan   +9 more
wiley   +1 more source

[Chronic gastritis].

Revista medica de Chile, 1971
M, Davila, F, Rufin, P, Ossa, M, Silva, M, Contreras, V, Schiappacasse, A, Reid, V, Martinez   +7 more
openaire   +1 more source

Post-COVID-19 Effects on Chronic Gastritis and Gastric Cellular and Molecular Characteristics in Male Mice. [PDF]

Cell Mol Gastroenterol Hepatol
Jeong H, Kim SH, Kim J, Jeon D, Uhm C, Oh H, Cho K, Park IH, Oh J, Kim JJ, Jeong SH, Park JH, Park JW, Yun JW, Seo JY, Shin JS, Goldenring JR, Seong JK, Nam KT.   +18 more
europepmc   +1 more source

Efficacy and Safety of Vonoprazan‐Based Dual Therapies With Different Antibiotics Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four‐Arm, Randomized Controlled Trial

Helicobacter, Volume 31, Issue 3, May/June 2026.
ABSTRACT Background Vonoprazan‐based dual therapy has been proposed as a simplified strategy for Helicobacter pylori eradication, but head‐to‐head comparisons of different antibiotic partners are limited. We compared the efficacy, safety, and adherence of vonoprazan‐based dual regimens with those of bismuth‐containing quadruple therapy (BQT).
Jie Li, Deng‐Hua Li, Qi‐Qi Guo, Ju Zhang, Xiao‐Jing Zhu, Yu‐Hao Liu, Yan‐Peng Zhang, Min Chen, Yong‐Quan Shi   +8 more
wiley   +1 more source